Jove
Visualize
Contact Us

Related Experiment Videos

Mitochondrial toxicity and HIV therapy.

A J White1

  • 1Anti-Infectives Clinical Development and Product Strategy, GlaxoSmithKline Research and Development, Greenford Road, Greenford, Middlesex, UB6 0HE, UK. ajw5819@glaxowellcome.co.uk

Sexually Transmitted Infections
|June 13, 2001
PubMed
Summary

Nucleoside reverse transcriptase inhibitors (NRTIs) used in HIV treatment can cause side effects by damaging mitochondria. This damage affects mitochondrial DNA replication, potentially leading to cellular dysfunction and varied toxicities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inclusive Search for Anomalous Single-Photon Production in MicroBooNE.

Physical review letters·2026
Same author

First Search for Dark Sector e^{+}e^{-} Explanations of the MiniBooNE Anomaly at MicroBooNE.

Physical review letters·2026
Same author

Sleep disturbance and brain health in professional association footballers.

Frontiers in sports and active living·2026
Same author

First Measurement of Charged-Current Muon-Neutrino-Induced K^{+} Production on Argon Using the MicroBooNE Detector.

Physical review letters·2026
Same author

Search for an Anomalous Production of Charged-Current ν_{e} Interactions without Visible Pions across Multiple Kinematic Observables in MicroBooNE.

Physical review letters·2025
Same author

First Measurement of ν_{e} and ν[over ¯]_{e} Charged-Current Single Charged-Pion Production Differential Cross Sections on Argon Using the MicroBooNE Detector.

Physical review letters·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Nucleoside reverse transcriptase inhibitors (NRTIs) are crucial in highly active antiretroviral therapy (HAART) for HIV/AIDS.
  • NRTI-associated toxicities are frequently linked to mitochondrial dysfunction.
  • Mitochondria possess their own DNA and a unique replication enzyme, polymerase gamma, which NRTIs can inhibit.

Purpose of the Study:

  • To review the major toxicities associated with NRTI therapy.
  • To examine the evidence linking these toxicities to mitochondrial dysfunction.
  • To explore the mechanisms and implications of NRTI-induced mitochondrial damage.

Main Methods:

  • Literature review of online databases (Medline, Current Contents).
  • Inclusion of conference abstracts and posters from HIV and mitochondrial research.

Related Experiment Videos

  • Analysis of clinical and in vitro studies investigating NRTI effects on mitochondria.

    • Main Results:

    • NRTIs can impair polymerase gamma, leading to mitochondrial DNA depletion or qualitative changes.
    • Mitochondrial dysfunction involves heteroplasmy and threshold effects, complicating prediction of tissue-specific toxicity.
    • Evidence suggests NRTIs are associated with mitochondrial dysfunction in various tissues, though data are sometimes limited.

    Conclusions:

    • NRTI-induced mitochondrial dysfunction is a significant factor in their toxicity profile.
    • Understanding NRTI-mitochondria interactions is key to managing side effects.
    • Further research is needed to elucidate tissue-specific effects and drug distribution patterns.